Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States The company operates through two segments, Retail Pharmacy and Pharmacy Services.
infoRite Aid is a micro cap stock with a total market cap of 87.37M.
infoThey trade on the NYSE and had their IPO 43 years and 5 months ago.
infoRite Aid currently employs 47000 people.
infoAs of Wednesday, Aug 23 2023, Rite Aid’s share price is $1.49.
News Relating to Rite Aid
CNBC
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
Monday Aug 21 2023 at 11:40
Analysts said blockbuster weight loss drugs like Wegovy are minimally profitable for retailers like Walmart – and may even come with slight margin headwinds.
InvestorPlace
TTOO vs. RAD Stock: Which New Meme Stock Is the Worst Buy?
Wednesday Aug 09 2023 at 16:47
Earlier this week, InvestorPlace’s Thomas Yeung posed an interesting question: Could Rite Aid (NYSE: RAD ) become the next big meme stock? As meme stocks surged last week, The Wall Street Journal flagged the struggling pharmaceutical chain as a likely contender for the next r/WallStreetBets favorite.
InvestorPlace
Could Rite Aid Become the Next AMC Meme Stock?
Tuesday Aug 08 2023 at 16:39
Last week, meme investors “discovered” Rite Aid (NYSE: RAD ), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown.
CNBC Television
Retail traders swarm Rite Aid shares in latest meme stock rally
Monday Aug 07 2023 at 11:40
CNBC’s Kate Rooney reports on news regarding Rite Aid, and other popular shorts.
InvestorPlace
Rite Aid Short Squeeze Takes RAD Stock 6% Higher
Friday Aug 04 2023 at 15:11
Shares of Rite Aid (NYSE: RAD ) stock are bouncing higher on Friday, up about 5.5% at the moment. At today’s high, RAD stock was up roughly 23%.
PennyStocks
Best Penny Stocks To Buy? 3 To Watch With Unusual Options Action
Friday Aug 04 2023 at 14:09
Retail investors are on the prowl for the best penny stocks to invest in. We’ve touched on several unique trends currently influencing the stock market, including sentiment-driven sympathy trades.
The Motley Fool
Why Shares of Rite Aid Soared This Week
Friday Aug 04 2023 at 12:16
Rite Aid has not had a profitable year since 2018. The company reported a loss of $306 million in its last quarterly report.
InvestorPlace
Is a Giant Short Squeeze Brewing in Rite Aid (RAD) Stock?
Thursday Aug 03 2023 at 09:40
Yesterday, Rite Aid (NYSE: RAD ) stock had its best day since 2019 after being identified as a short squeeze. Shares in the pharmacy chain rose over 31% after Fintel reported that 23% of the company’s stock was being held short, and 51% of its off-exchange volume was short.
PennyStocks
Best Penny Stocks To Watch After Fitch Downgrade? 3 For Your List
Wednesday Aug 02 2023 at 12:15
Penny stocks are an interesting asset class. On any given day, you will see at least a handful experiencing extreme levels and explosive moves.
Zacks Investment Research
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
Wednesday Jul 19 2023 at 12:52
The Zacks Retail Pharmacy and Drugstore industry players like CVS, HLF and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
Zacks Investment Research
Can Rite Aid (RAD) Stock Bounce Back on Growth Endeavors?
Monday Jul 10 2023 at 12:30
Despite drab demand and headwinds at Elixir Insurance, Rite Aid’s (RAD) solid online show, strength in the Retail Pharmacy segment and cost-saving initiatives are likely to aid growth.
Forbes
Rite Aid Not Ruling Out More Store Closures As Losses Mount
Saturday Jul 01 2023 at 08:00
Rite Aid executives aren’t ruling out more store closures as the company sustains more financial losses while they’re working their turnaround plan.
MarketBeat
Rite Aid Could Become An Acquisition Target
Friday Jun 30 2023 at 07:01
Shares of Rite Aid NYSE: RAD have been on a sluggish path to becoming a near-penny stock, despite being one of the most entrenched brands in American Households. This name has become synonymous with children’s ‘boo boos’ and first-aid kits.
PYMNTS
Rite Aid Rides Ozempic Wave but Fails to Profit
Thursday Jun 29 2023 at 17:36
During its fiscal first quarter, Rite Aid reported a boost in pharmacy sales, attributed to the introduction of a new category of drugs. Pharmacy sales rose 3.4% year over year, fueled by the demand for Ozempic and other GLP-1 receptor agonists.
Zacks Investment Research
Rite Aid (RAD) Q1 Loss Narrower Than Expected, Revenues Beat
Thursday Jun 29 2023 at 13:39
Rite Aid’s (RAD) Q1 results gain from solid pharmacy margins and progress in its turnaround program. Lower revenues from COVID-19 vaccines and testing, and store closures are headwinds.
Yahoo Finance
Rite Aid falling behind pharmacy competitors after reporting earnings
Thursday Jun 29 2023 at 11:42
Shares of Rite Aid are slightly up following the company’s first quarter earnings release, despite a decrease in revenue. Yahoo Finance Live details where Rite Aid ranks amongst its pharmaceutical competitors, CVS and Walgreens Boots Alliance.
Market Watch
Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid
Thursday Jun 29 2023 at 11:39
Rite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost from a new class of drug.
Zacks Investment Research
Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates
Thursday Jun 29 2023 at 09:54
Rite Aid (RAD) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $1.49. This compares to loss of $0.60 per share a year ago.
Forbes
Rite Aid Loss Hits $306 Million As Troubles Mount
Thursday Jun 29 2023 at 07:30
Rite Aid reported a quarterly loss of more than $306 million as the drugstore chain grapples with the loss of customers from its pharmacy benefit business.
Market Watch
Rite Aid’s stock soars 7.5% premarket after company posts narrower-than-expected loss and revenue beat
Thursday Jun 29 2023 at 07:14
Rite Aid Corp.’s stock RAD, -4.40% rose 7.5% in premarket trade Thursday, after the drug store chain posted a narrower-than-expected loss for its fiscal first quarter and better-than-expected revenue. The Philadelphia-based company posted a net loss of $306.7 million, or $5.56 a share, for the quarter to June 3, wider than the loss of $110.2 million, or $2.03 a share, posted in the year-earlier period.
Market Watch
Rite Aid’s stock slides to fresh record low ahead of earnings due Thursday
Wednesday Jun 28 2023 at 14:04
Rite Aid Corp.’s stock RAD, -3.15% slid another 3.8% Wednesday to a fresh record low, bringing its five-day loss to 23%. The stock has been under pressure since a Bloomberg report last week that the company is working with banks and lawyers to reorganize its debt, which totals about $2.9 billion, the bulk of which comes due in 2025 and 2026.
Market Watch
Rite Aid’s stock slides to record low amid concerns about possible restructuring of $2.9 billion of debt
Tuesday Jun 27 2023 at 14:37
Rite Aid Corp.’s stock tumbled 13% Tuesday to a record low, amid concerns prompted by a Bloomberg report last week that the company is working with banks and lawyers to reorganize its debt.
Market Watch
Q2 profits are set for their biggest drop since the pandemic, but then the worst may be over for the year
Saturday Jun 24 2023 at 13:19
Wall Street is expecting a third straight quarter of falling profits and the worst decrease since the pandemic in 2020, when second quarter earnings are reported in July, but that may be the bottom for this year.
Business Wire
Rite Aid to Release First Quarter Results on June 29
Monday Jun 12 2023 at 08:30
PHILADELPHIA–(BUSINESS WIRE)–Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2024 First Quarter, which ended June 3, 2023, on Thursday, June 29, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid’s management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, June 29, 2023, through 11:59 p.m. ET on July 29, 2023. To access the replay o.
InvestorPlace
7 Penny Stocks to Sell in June Before They Crash and Burn
Sunday Jun 11 2023 at 16:42
“Price is what you pay, value is what you get.” This famed Warren Buffett investing maxim can serve you well when determining whether a penny stock (stock trading for $5 per share or less) is worthy of a buy, or if it is one of the penny stocks to sell.
InvestorPlace
7 Overvalued Penny Stocks to Sell Before June 2023
Sunday May 28 2023 at 19:49
While there are plenty of bargains to buy among penny stocks, there are also a good amount of overvalued penny stocks to sell. While significantly lower-priced now than they were at their respective high water-marks, many of these stocks are hardly bargains, trading at valuations unsustainable relative to their current operating performance.
Market Watch
Bio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.
Friday May 05 2023 at 12:31
Shares of Bio-Rad Laboratories Inc. BIO tumbled 17.5% toward their worst day in 36 years, after the maker of products for the life science research and clinical diagnostics markets reported first-quarter results that missed expectations, amid a drop in COVID-related sales, and cut its full-year outlook. The stock, which paced the S&P 500’s SPX decliners, was headed for the biggest one-day decline since it plunged 23.5% on Oct. 20, 1987.
Zacks Investment Research
3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry
Monday Apr 24 2023 at 12:12
Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.
Schaeffers Research
Rite Aid Stock Suffers Post-Earnings Slide
Thursday Apr 20 2023 at 10:31
Rite Aid Corp (NYSE:RAD) stock is down 9.3% to trade at $2.15 at last glance, after the company’s wider-than-expected first-quarter losses of $1.24 per share.
Zacks Investment Research
Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates
Thursday Apr 20 2023 at 09:56
Rite Aid (RAD) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.63 per share a year ago.
Rite Aid Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
Rite Aid’s Altman Z-score is 1.92 which is in the gray zone. This indicates a level of ambiguity where further analyses are needed to evaluate the company’s financial stability accurately.
Derived from SEC.GOV filing dataopen_in_new
Rite Aid Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, there has been no insider trading in Rite Aid.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
Rite Aid’s Income Quality of 0.18 is greater than its Industry Group of 0.13 (38.5% greater)
Rite Aid’s Income Quality of 0.18 is lower than its Major Industry Group of 0.52 (-65.4% lower)
Rite Aid’s Income Quality of 0.18 is lower than its Sector of 0.87 (-79.3% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
Rite Aid’s Current Ratio of 1.32 is greater than its Industry Group of 1.19 (10.9% greater)
Rite Aid’s Current Ratio of 1.32 is lower than its Major Industry Group of 1.59 (-17.0% lower)
Rite Aid’s Current Ratio of 1.32 is in line with its Sector of 1.37 (-3.6% lower)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-0.09 & -5.42)
Cannot compare a negative PE Ratio (-0.09 & -0.23)
Cannot compare a negative PE Ratio (-0.09 & 5.99)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
Cannot compare a negative PB Ratio (-0.09 & 1.6)
Cannot compare a negative PB Ratio (-0.09 & 1.38)
Cannot compare a negative PB Ratio (-0.09 & 1.57)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
Rite Aid’s ROE of 1.0 is greater than its Industry Group of -0.32 (412.5% greater)
Cannot compute a percentage difference when there are zeros in the calculation
Rite Aid’s ROE of 1.0 is greater than its Sector of 0.08 (1150.0% greater)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
Rite Aid’s ROCE of -0.06 is greater than its Industry Group of -0.21 (71.4% greater)
Rite Aid’s ROCE of -0.06 is lower than its Major Industry Group of -0.02 (-200.0% lower)
Rite Aid’s ROCE of -0.06 is lower than its Sector of 0.06 (-200.0% lower)
Derived from SEC.GOV filing dataopen_in_new